Virus infection, antiviral immunity, and autoimmunity

Immunological Reviews

Volumn 255, Issue 1, 2013, Pages 197-209

  Getts, Daniel R ^a   Chastain, Emily M L ^a   Terry, Rachael L ^a   Miller, Stephen D ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Autoimmune disease; Bystander activation; Epitope spreading; Microbial superantigens; Molecular mimicry; T cell receptor affinity

Indexed keywords

ADJUVANT; ANTIVIRUS AGENT; CYTOKINE; DOUBLE STRANDED DNA; DYNEIN ADENOSINE TRIPHOSPHATASE; EPITOPE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12; INTERLEUKIN 1BETA; KINESIN; MAJOR HISTOCOMPATIBILITY ANTIGEN; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN PROTEIN; RANTES; RETINOIC ACID INDUCIBLE PROTEIN I; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR;

ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ANTIVIRAL ACTIVITY; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BLOOD BRAIN BARRIER; BRAIN; BYSTANDER EFFECT; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASE; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; EPSTEIN BARR VIRUS; FLAVIVIRUS; HERPES VIRUS; HORSE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; IMMUNOPATHOLOGY; IMMUNOREACTIVITY; IMMUNOSURVEILLANCE; IN VITRO STUDY; IN VIVO STUDY; JAPANESE ENCEPHALITIS VIRUS; MAJOR HISTOCOMPATIBILITY COMPLEX; MEASLES VIRUS; MEMORY CELL; MOLECULAR MIMICRY; MORTALITY; MULTIPLE SCLEROSIS; MURINE ENCEPHALOMYELITIS VIRUS; NERVE FIBER TRANSPORT; NONHUMAN; PARAMYXOVIRUS; PATHOGENICITY; PERIPHERAL NERVE; PODOCYTE; PRIORITY JOURNAL; REVIEW; SEMLIKI FOREST ALPHAVIRUS; SIGNAL TRANSDUCTION; SINDBIS VIRUS; STREPTOCOCCUS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TROPICAL SPASTIC PARAPARESIS; VIRUS CELL INTERACTION; VIRUS ENCEPHALITIS; VIRUS ENTRY; VIRUS INFECTION; VIRUS PATHOGENESIS; VIRUS STRAIN; WEST NILE FLAVIVIRUS;

AUTOIMMUNE DISEASE; BYSTANDER ACTIVATION; EPITOPE SPREADING; MICROBIAL SUPERANTIGENS; MOLECULAR MIMICRY; T-CELL RECEPTOR AFFINITY;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CENTRAL NERVOUS SYSTEM; HUMANS; VIRUS DISEASES; VIRUSES;

EID: 84881645874     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/imr.12091     Document Type: Review

References (163)

1. Graus F, Dalmau J. CNS autoimmunity: new findings and pending issues. Lancet Neurol 2012;11:17-19.
2. Bluestone JA, Herold K, Eisenbarth G. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 2010;464:1293-1300.
3. Sollid LM, Jabri B. Triggers and drivers of autoimmunity: lessons from coeliac disease. Nat Rev Immunol 2013;13:294-302.
4. Goverman J. Autoimmune T cell responses in the central nervous system. Nat Rev Immunol 2009;9:393-407.
5. Gregersen PK, Behrens TW. Genetics of autoimmune diseases-disorders of immune homeostasis. Nat Rev Genet 2006;7:917-928.
6. Zhernakova A, van Diemen CC, Wijmenga C. Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat Rev Genet 2009;10:43-55.
7. Kivity S, Agmon-Levin N, Blank M, Shoenfeld Y. Infections and autoimmunity-friends or foes? Trends Immunol 2009;30:409-414.
8. Sfriso P, et al. Infections and autoimmunity: the multifaceted relationship. J Leukoc Biol 2010;87:385-395.
9. Pollard KM, Kono DH. Requirements for innate immune pathways in environmentally induced autoimmunity. BMC Med 2013;11:100.
10. Lunemann JD. Epstein-Barr virus in multiple sclerosis: a continuing conundrum. Neurology 2012;78:11-12.
11. Tucker WG, Andrew Paskauskas R. The MSMV hypothesis: measles virus and multiple sclerosis, etiology and treatment. Med Hypotheses 2008;71:682-689.
12. Chastain EM, Duncan DS, Rodgers JM, Miller SD. The role of antigen presenting cells in multiple sclerosis. Biochim Biophys Acta 2011;1812:265-274.
13. Chastain EM, Miller SD. Molecular mimicry as an inducing trigger for CNS autoimmune demyelinating disease. Immunol Rev 2012;245:227-238.
14. Das Sarma J, et al. Demyelinating and nondemyelinating strains of mouse hepatitis virus differ in their neural cell tropism. J Virol 2008;82:5519-5526.
15. Christophi GP, Hudson CA, Panos M, Gruber RC, Massa PT. Modulation of macrophage infiltration and inflammatory activity by the phosphatase SHP-1 in virus-induced demyelinating disease. J Virol 2009;83:522-539.
16. Dale RC. Post-streptococcal autoimmune disorders of the central nervous system. Dev Med Child Neurol 2005;47:785-791.
17. McArthur JC. HIV dementia: an evolving disease. J Neuroimmunol 2004;157:3-10.
18. Ito Y, et al. Exacerbation of herpes simplex encephalitis after successful treatment with acyclovir. Clin Infect Dis 2000;30:185-187.
19. Utley TF, Ogden JA, Gibb A, McGrath N, Anderson NE. The long-term neuropsychological outcome of herpes simplex encephalitis in a series of unselected survivors. Neuropsychiatry Neuropsychol Behav Neurol 1997;10:180-189.
20. Oger J. HTLV-1 infection and the viral etiology of multiple sclerosis. J Neurol Sci 2007;262:100-104.
21. Faulkner GC, Krajewski AS, Crawford DH. The ins and outs of EBV infection. Trends Microbiol 2000;8:185-189.
22. Casiraghi C, Dorovini-Zis K, Horwitz MS. Epstein-Barr virus infection of human brain microvessel endothelial cells: a novel role in multiple sclerosis. J Neuroimmunol 2011;230:173-177.
23. Williams H, Crawford DH. Epstein-Barr virus: the impact of scientific advances on clinical practice. Blood 2006;107:862-869.
24. Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004;4:757-768.
25. Owens GP, Bennett JL. Trigger, pathogen, or bystander: the complex nexus linking Epstein- Barr virus and multiple sclerosis. Mult Scler 2012;18:1204-1208.
26. Ascherio A, Munch M. Epstein-Barr virus and multiple sclerosis. Epidemiology 2000;11:220-224.
27. Wucherpfennig KW, Strominger JL. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995;80:695-705.
28. Willis SN, et al. Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain. Brain 2009;132:3318-3328.
29. Peferoen LA, et al. Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis. Brain 2010;133:e137.
30. Sargsyan SA, et al. Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis. Neurology 2010;74:1127-1135.
31. Ahlgren C, Oden A, Bergstrom T, Lycke J. Serum and CSF measles antibody levels increase over time in patients with multiple sclerosis or clinically isolated syndrome. J Neuroimmunol 2012;247:70-74.
32. Young VA, Rall GF. Making it to the synapse: measles virus spread in and among neurons. Curr Top Microbiol Immunol 2009;330:3-30.
33. Lee SM, Morcos Y, Jang H, Stuart JM, Levin MC. HTLV-1 induced molecular mimicry in neurological disease. Curr Top Microbiol Immunol 2005;296:125-136.
34. Mecha M, Carrillo-Salinas FJ, Mestre L, Feliu A, Guaza C. Viral models of multiple sclerosis: Neurodegeneration and demyelination in mice infected with Theiler's virus. Prog Neurobiol 2013;101-102:46-64.
35. McMahon EJ, Bailey SL, Castenada CV, Waldner H, Miller SD. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat Med 2005;11:335-339.
36. Gerety SJ, et al. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. V. Mapping of a dominant immunopathologic VP2 T cell epitope in susceptible SJL/J mice. J Immunol 1994;152:908-918.
37. Olson JK, Croxford JL, Miller SD. Virus-induced autoimmunity: Potential role of viruses in initiation, perpetuation, and progression of T cell-mediated autoimmune diseases. Viral Immunol 2001;14:227-250.
38. Reddi HV, Kumar AS, Kung AY, Kallio PD, Schlitt BP, Lipton HL. Heparan sulfate-independent infection attenuates high-neurovirulence GDVII virus-induced encephalitis. J Virol 2004;78:8909-8916.
39. Zoecklein LJ, et al. Direct comparison of demyelinating disease induced by the Daniel's strain and BeAn strain of Theiler's murine encephalomyelitis virus. Brain Pathol 2003;13:291-308.
40. Kang BS, Yahikozawa H, Koh CS, Kim BS. Oral administration of live virus protects susceptible mice from developing Theiler's virus-induced demyelinating disease. Virology 2007;366:185-196.
41. Mokhtarian F, Huan CM, Roman C, Raine CS. Semliki Forest virus-induced demyelination and remyelination-involvement of B cells and anti-myelin antibodies. J Neuroimmunol 2003;137:19-31.
42. Subak-Sharpe I, Dyson H, Fazakerley J. In vivo depletion of CD8+ T cells prevents lesions of demyelination in Semliki Forest virus infection. J Virol 1993;67:7629-7633.
43. Tseng YF, Wang CC, Liao SK, Chuang CK, Chen WJ. Autoimmunity-related demyelination in infection by Japanese encephalitis virus. J Biomed Sci 2011;18:20.
44. Liu TH, Liang LC, Wang CC, Liu HC, Chen WJ. The blood-brain barrier in the cerebrum is the initial site for the Japanese encephalitis virus entering the central nervous system. J Neurovirol 2008;14:514-521.
45. Horner PJ, Gage FH. Regenerating the damaged central nervous system. Nature 2000;407:963-970.
46. Chaudhuri A, Kennedy PG. Diagnosis and treatment of viral encephalitis. Postgrad Med J 2002;78:575-583.
47. Whitley RJ, Gnann JW. Viral encephalitis: familiar infections and emerging pathogens. Lancet 2002;359:507-513.
48. Engelhardt B, Sorokin L. The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction. Semin Immunopathol 2009;31:497-511.
49. Muldoon LL, et al. Immunologic privilege in the central nervous system and the blood-brain barrier. J Cereb Blood Flow Metab 2013;33:13-21.
50. Zhang JR, Tuomanen E. Molecular and cellular mechanisms for microbial entry into the CNS. J Neurovirol 1999;5:591-603.
51. German AC, et al. A preliminary neuropathological study of Japanese encephalitis in humans and a mouse model. Trans R Soc Trop Med Hyg 2006;100:1135-1145.
52. Soilu-Hanninen M, Eralinna JP, Hukkanen V, Roytta M, Salmi AA, Salonen R. Semliki Forest virus infects mouse brain endothelial cells and causes blood-brain barrier damage. J Virol 1994;68:6291-6298.
53. Ho DD, Rota TR, Hirsch MS. Infection of human endothelial cells by human T-lymphotropic virus type I. Proc Natl Acad Sci USA 1984;81:7588-7590.
54. Hoxie JA, Matthews DM, Cines DB. Infection of human endothelial cells by human T-cell leukemia virus type I. Proc Natl Acad Sci USA 1984;81:7591-7595.
55. Romero IA, et al. Interactions between brain endothelial cells and human T-cell leukemia virus type 1-infected lymphocytes: mechanisms of viral entry into the central nervous system. J Virol 2000;74:6021-6030.
56. Serafini B, et al. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med 2007;204:2899-2912.
57. King NJ, Getts DR, Getts MT, Rana S, Shrestha B, Kesson AM. Immunopathology of flavivirus infections. Immunol Cell Biol 2007;85:33-42.
58. Ehrengruber MU, Ehler E, Billeter MA, Naim HY. Measles virus spreads in rat hippocampal neurons by cell-to-cell contact and in a polarized fashion. J Virol 2002;76:5720-5728.
59. Martinat C, Jarousse N, Prevost MC, Brahic M. The GDVII strain of Theiler's virus spreads via axonal transport. J Virol 1999;73:6093-6098.
60. Hsieh MJ, White PJ, Pouton CW. Interaction of viruses with host cell molecular motors. Curr Opin Biotechnol 2010;21:633-639.
61. Getts DR, et al. Ly6c+ "inflammatory monocytes" are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis. J Exp Med 2008;205:2319-2337.
62. Wada Y, Pierce ML, Fujinami RS. Importance of amino acid 101 within capsid protein VP1 for modulation of Theiler's virus-induced disease. J Virol 1994;68:1219-1223.
63. Oldstone MB, et al. Measles virus infection in a transgenic model: virus-induced immunosuppression and central nervous system disease. Cell 1999;98:629-640.
64. Villarreal D, Young CR, Storts R, Ting JW, Welsh CJ. A comparison of the neurotropism of Theiler's virus and poliovirus in CBA mice. Microb Pathog 2006;41:149-156.
65. Burkala EJ, He J, West JT, Wood C, Petito CK. Compartmentalization of HIV-1 in the central nervous system: role of the choroid plexus. AIDS 2005;19:675-684.
66. Falangola MF, Hanly A, Galvao-Castro B, Petito CK. HIV infection of human choroid plexus: a possible mechanism of viral entry into the CNS. J Neuropathol Exp Neurol 1995;54:497-503.
67. Petito CK, Chen H, Mastri AR, Torres-Munoz J, Roberts B, Wood C. HIV infection of choroid plexus in AIDS and asymptomatic HIV-infected patients suggests that the choroid plexus may be a reservoir of productive infection. J Neurovirol 1999;5:670-677.
68. Herndon RM, Johnson RT, Davis LE, Descalzi LR. Ependymitis in mumps virus meningitis. Electron microscopical studies of cerebrospinal fluid. Arch Neurol 1974;30:475-479.
69. Coscoy L, Gonzalez-Dunia D, Brahic M, Ozden S. Infection of choroid plexus cells by human T cell leukaemia virus type I. J Gen Virol 1997;78:143-146.
70. Lawrence DM, Patterson CE, Gales TL, D'Orazio JL, Vaughn MM, Rall GF. Measles virus spread between neurons requires cell contact but not CD46 expression, syncytium formation, or extracellular virus production. J Virol 2000;74:1908-1918.
71. Terry RL, Getts DR, Deffrasnes C, van Vreden C, Campbell IL, King NJ. Inflammatory monocytes and the pathogenesis of viral encephalitis. J Neuroinflammation 2012;9:270.
72. Teodoro JG, Branton PE. Regulation of apoptosis by viral gene products. J Virol 1997;71:1739-1746.
73. Fujinami RS, von Herrath MG, Christen U, Whitton JL. Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin Microbiol Rev 2006;19:80-94.
74. Clarke P, Tyler KL. Apoptosis in animal models of virus-induced disease. Nat Rev Microbiol 2009;7:144-155.
75. Zong WX, Thompson CB. Necrotic death as a cell fate. Genes Dev 2006;20:1-15.
76. Hood C, Cunningham AL, Slobedman B, Boadle RA, Abendroth A. Varicella-zoster virus-infected human sensory neurons are resistant to apoptosis, yet human foreskin fibroblasts are susceptible: evidence for a cell-type-specific apoptotic response. J Virol 2003;77:12852-12864.
77. Konig A, Homme C, Hauroder B, Dietrich A, Wolff MH. The varicella-zoster virus induces apoptosis in vitro in subpopulations of primary human peripheral blood mononuclear cells. Microbes Infect 2003;5:879-889.
78. Baiker A, et al. Varicella-zoster virus infection of human neural cells in vivo. Proc Natl Acad Sci USA 2004;101:10792-10797.
79. Nargi-Aizenman JL, Griffin DE. Sindbis virus-induced neuronal death is both necrotic and apoptotic and is ameliorated by N-methyl-D-aspartate receptor antagonists. J Virol 2001;75:7114-7121.
80. Levine B, Huang Q, Isaacs JT, Reed JC, Griffin DE, Hardwick JM. Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene. Nature 1993;361:739-742.
81. Lewis J, Wesselingh SL, Griffin DE, Hardwick JM. Alphavirus-induced apoptosis in mouse brains correlates with neurovirulence. J Virol 1996;70:1828-1835.
82. Irusta PM, Hardwick JM. Neuronal apoptosis pathways in Sindbis virus encephalitis. Prog Mol Subcell Biol 2004;36:71-93.
83. Griffin DE. Neuronal cell death in alphavirus encephalomyelitis. Curr Top Microbiol Immunol 2005;289:57-77.
84. Anderson R, Harting E, Frey MS, Leibowitz JL, Miranda RC. Theiler's murine encephalomyelitis virus induces rapid necrosis and delayed apoptosis in myelinated mouse cerebellar explant cultures. Brain Res 2000;868:259-267.
85. Havert MB, Schofield B, Griffin DE, Irani DN. Activation of divergent neuronal cell death pathways in different target cell populations during neuroadapted sindbis virus infection of mice. J Virol 2000;74:5352-5356.
86. Ishii KJ, Koyama S, Nakagawa A, Coban C, Akira S. Host innate immune receptors and beyond: making sense of microbial infections. Cell Host Microbe 2008;3:352-363.
87. Kumar H, Kawai T, Akira S. Pathogen recognition by the innate immune system. Int Rev Immunol 2011;30:16-34.
88. Liang XH, Goldman JE, Jiang HH, Levine B. Resistance of interleukin-1beta-deficient mice to fatal Sindbis virus encephalitis. J Virol 1999;73:2563-2567.
89. Libbey JE, Kennett NJ, Wilcox KS, White HS, Fujinami RS. Interleukin-6, produced by resident cells of the central nervous system and infiltrating cells, contributes to the development of seizures following viral infection. J Virol 2011;85:6913-6922.
90. Kapil P, Atkinson R, Ramakrishna C, Cua DJ, Bergmann CC, Stohlman SA. Interleukin-12 (IL-12), but not IL-23, deficiency ameliorates viral encephalitis without affecting viral control. J Virol 2009;83:5978-5986.
91. Chen BP, Lane TE. Lack of nitric oxide synthase type 2 (NOS2) results in reduced neuronal apoptosis and mortality following mouse hepatitis virus infection of the central nervous system. J Neurovirol 2002;8:58-63.
92. Getts DR, et al. Targeted blockade in lethal West Nile virus encephalitis indicates a crucial role for very late antigen (VLA)-4-dependent recruitment of nitric oxide-producing macrophages. J Neuroinflammation 2012;9:246.
93. Getts MT, Kim BS, Miller SD. Differential outcome of tolerance induction in naive versus activated Theiler's virus epitope-specific CD8+ cytotoxic T cells. J Virol 2007;81:6584-6593.
94. Bennett JL, Elhofy A, Charo I, Miller SD, Dal Canto MC, Karpus WJ. CCR2 regulates development of Theiler's murine encephalomyelitis virus-induced demyelinating disease. Viral Immunol 2007;20:19-33.
95. Glass WG, Liu MT, Kuziel WA, Lane TE. Reduced macrophage infiltration and demyelination in mice lacking the chemokine receptor CCR5 following infection with a neurotropic coronavirus. Virology 2001;288:8-17.
96. Wu GF, Dandekar AA, Pewe L, Perlman S. CD4 and CD8 T cells have redundant but not identical roles in virus-induced demyelination. J Immunol 2000;165:2278-2286.
97. Fujinami RS, Oldstone MB. Molecular mimicry as a mechanism for virus-induced autoimmunity. Immunol Res 1989;8:3-15.
98. Fujinami RS, Oldstone MB. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science 1985;230:1043-1045.
99. Hammer J, Sturniolo T, Sinigaglia F. HLA class II peptide binding specificity and autoimmunity. Adv Immunol 1997;66:67-100.
100. Gautam AM, Lock CB, Smilek DE, Pearson CI, Steinman L, McDevitt HO. Minimum structural requirements for peptide presentation by major histocompatibility complex class II molecules: implications in induction of autoimmunity. Proc Natl Acad Sci USA 1994;91:767-771.
101. Wucherpfennig KW, et al. Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones. J Exp Med 1994;179:279-290.
102. Hemmer B, et al. Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease. Nat Med 1999;5:1375-1382.
103. Lang HL, et al. A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat Immunol 2002;3:940-943.
104. Croxford JL, Olson JK, Miller SD. Epitope spreading and molecular mimicry as triggers of autoimmunity in the Theiler's virus-induced demyelinating disease model of multiple sclerosis. Autoimmun Rev 2002;1:251-260.
105. Massilamany C, Asojo OA, Gangaplara A, Steffen D, Reddy J. Identification of a second mimicry epitope from Acanthamoeba castellanii that induces CNS autoimmunity by generating cross-reactive T cells for MBP 89-101 in SJL mice. Int Immunol 2011;23:729-739.
106. Massilamany C, Steffen D, Reddy J. An epitope from Acanthamoeba castellanii that cross-react with proteolipid protein 139-151-reactive T cells induces autoimmune encephalomyelitis in SJL mice. J Neuroimmunol 2010;219:17-24.
107. Zhao ZS, Granucci F, Yeh L, Schaffer PA, Cantor H. Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science 1998;279:1344-1347.
108. Coppieters KT, Wiberg A, von Herrath MG. Viral infections and molecular mimicry in type 1 diabetes. APMIS 2012;120:941-949.
109. Mokhtarian F, Zhang Z, Shi Y, Gonzales E, Sobel RA. Molecular mimicry between a viral peptide and a myelin oligodendrocyte glycoprotein peptide induces autoimmune demyelinating disease in mice. J Neuroimmunol 1999;95:43-54.
110. Gauntt CJ, et al. Molecular mimicry, anti-coxsackievirus B3 neutralizing monoclonal antibodies, and myocarditis. J Immunol 1995;154:2983-2995.
111. Lawson CM. Evidence for mimicry by viral antigens in animal models of autoimmune disease including myocarditis. Cell Mol Life Sci 2000;57:552-560.
112. Oldstone MB, Nerenberg M, Southern P, Price J, Lewicki H. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 1991;65:319-331.
113. Ohashi PS, et al. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 1991;65:305-317.
114. von Herrath MG, Dockter J, Oldstone MB. How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model. Immunity 1994;1:231-242.
115. Evans CF, Horwitz MS, Hobbs MV, Oldstone MB. Viral infection of transgenic mice expressing a viral protein in oligodendrocytes leads to chronic central nervous system autoimmune disease. J Exp Med 1996;184:2371-2384.
116. Olson JK, Croxford JL, Calenoff M, Dal Canto MC, Miller SD. A virus-induced molecular mimicry model of multiple sclerosis. J Clin Invest 2001;108:311-318.
117. Carrizosa AM, et al. Expansion by self antigen is necessary for the induction of experimental autoimmune encephalomyelitis by T cells primed with a cross-reactive environmental antigen. J Immunol 1998;161:3307-3314.
118. Croxford JL, Ercolini AM, Degutes M, Miller SD. Structural requirements for initiation of cross-reactivity and CNS autoimmunity with a PLP139-151 mimic peptide derived from murine hepatitis virus. Eur J Immunol 2006;36:2671-2680.
119. Greene MT, Ercolini AM, Degutes M, Miller SD. Differential induction of experimental autoimmune encephalomyelitis by myelin basic protein molecular mimics in mice humanized for HLA-DR2 and an MBP(85-99)-specific T cell receptor. J Autoimmun 2008;31:399-407.
120. Christen U, et al. A viral epitope that mimics a self antigen can accelerate but not initiate autoimmune diabetes. J Clin Invest 2004;114:1290-1298.
121. Yurasov S, et al. Defective B cell tolerance checkpoints in systemic lupus erythematosus. J Exp Med 2005;201:703-711.
122. Samuels J, Ng YS, Coupillaud C, Paget D, Meffre E. Impaired early B cell tolerance in patients with rheumatoid arthritis. J Exp Med 2005;201:1659-1667.
123. Lovett-Racke AE, Trotter JL, Lauber J, Perrin PJ, June CH, Racke MK. Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells. J Clin Invest 1998;101:725-730.
124. Markovic-Plese S, Cortese I, Wandinger KP, McFarland HF, Martin R. CD4+CD28- costimulation-independent T cells in multiple sclerosis. J Clin Invest 2001;108:1185-1194.
125. Bielekova B, Sung MH, Kadom N, Simon R, McFarland H, Martin R. Expansion and functional relevance of high-avidity myelin-specific CD4+ T cells in multiple sclerosis. J Immunol 2004;172:3893-3904.
126. Baranzini SE, Jeong MC, Butunoi C, Murray RS, Bernard CC, Oksenberg JR. B cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions. J Immunol 1999;163:5133-5144.
127. Babbe H, et al. Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med 2000;192:393-404.
128. Skulina C, et al. Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood. Proc Natl Acad Sci USA 2004;101:2428-2433.
129. Meinl E, et al. Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones. J Clin Invest 1993;92:2633-2643.
130. Goebels N, Hofstetter H, Schmidt S, Brunner C, Wekerle H, Hohlfeld R. Repertoire dynamics of autoreactive T cells in multiple sclerosis patients and healthy subjects: epitope spreading versus clonal persistence. Brain 2000;123:508-518.
131. Muraro PA, et al. Molecular tracking of antigen-specific T cell clones in neurological immune-mediated disorders. Brain 2003;126:20-31.
132. Thacker EL, Mirzaei F, Ascherio A. Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis. Ann Neurol 2006;59:499-503.
133. Nielsen TR, et al. Multiple sclerosis after infectious mononucleosis. Arch Neurol 2007;64:72-75.
134. Lunemann JD, et al. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis. Brain 2006;129:1493-1506.
135. Lunemann JD, et al. EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2. J Exp Med 2008;205:1763-1773.
136. Harari A, et al. Skewed association of polyfunctional antigen-specific CD8 T cell populations with HLA-B genotype. Proc Nat Acad Sci USA 2007;104:16233-16238.
137. Zipris D, Lien E, Xie JX, Greiner DL, Mordes JP, Rossini AA. TLR activation synergizes with Kilham rat virus infection to induce diabetes in BBDR rats. J Immunol 2005;174:131-142.
138. Walker LS, Abbas AK. The enemy within: keeping self-reactive T cells at bay in the periphery. Nat Rev Immunol 2002;2:11-19.
139. Enouz S, Carrie L, Merkler D, Bevan MJ, Zehn D. Autoreactive T cells bypass negative selection and respond to self-antigen stimulation during infection. J Exp Med 2012;209:1769-1779.
140. D'Agostino PM, et al. Viral-induced encephalitis initiates distinct and functional CD103+ CD11b+ brain dendritic cell populations within the olfactory bulb. Proc Natl Acad Sci USA 2012;109:6175-6180.
141. McRae BL, Vanderlugt CL, Dal Canto MC, Miller SD. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J Exp Med 1995;182:75-85.
142. Yu M, Johnson JM, Tuohy VK. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: A basis for peptide-specific therapy after onset of clinical disease. J Exp Med 1996;183:1777-1788.
143. Miller SD, et al. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat Med 1997;3:1133-1136.
144. Katz-Levy Y, et al. Endogenous presentation of self myelin epitopes by CNS-resident APCs in Theiler's virus-infected mice. J Clin Invest 1999;104:599-610.
145. Katz-Levy Y, et al. Temporal development of autoreactive Th1 responses and endogenous antigen presentation of self myelin epitopes by CNS-resident APCs in Theiler's virus-infected mice. J Immunol 2000;165:5304-5314.
146. Borrow P, Welsh CJ, Tonks P, Dean D, Blakemore WF, Nash AA. Investigation of the role of delayed-type-hypersensitivity responses to myelin in the pathogenesis of Theiler's virus-induced demyelinating disease. Immunology 1998;93:478-484.
147. Kaufman DL, et al. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 1993;366:69-72.
148. Prasad S, Kohm AP, McMahon JS, Luo X, Miller SD. Pathogenesis of NOD diabetes is initiated by reactivity to the insulin B chain 9-23 epitope and involves functional epitope spreading. J Autoimm 2012;39:347-353.
149. Wucherpfennig KW. Mechanisms for the induction of autoimmunity by infectious agents. J Clin Invest 2001;108:1097-1104.
150. Brocke S, et al. Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen. Nature 1993;365:642-644.
151. Cole BC, Griffiths MM. Triggering and exacerbation of autoimmune arthritis by the Mycoplasma arthritidis superantigen MAM. Arth Rheum 1993;36:994-1002.
152. Dalwadi H, Wei B, Kronenberg M, Sutton CL, Braun J. The Crohn's disease-associated bacterial protein I2 is a novel enteric T cell superantigen. Immunity 2001;15:149-158.
153. Pender MP. Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases. Trends Immunol 2003;24:584-588.
154. Thorley-Lawson DA, Gross A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 2004;350:1328-1337.
155. Nanbo A, Inoue K, Adachi-Takasawa K, Takada K. Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma. EMBO J 2002;21:954-965.
156. Mullbacher A, Hill AB, Blanden RV, Cowden WB, King NJ, Hla RT. Alloreactive cytotoxic T cells recognize MHC class I antigen without peptide specificity. J Immunol 1991;147:1765-1772.
157. King NJ, Maxwell LE, Kesson AM. Induction of class I major histocompatibility complex antigen expression by West Nile virus on gamma interferon-refractory early murine trophoblast cells. Proc Nat Acad Sci USA 1989;86:911-915.
158. Leis AA, Szatmary G, Ross MA, Stokic DS. West nile virus infection and myasthenia gravis. Muscle Nerve 2013; doi: 10.1002/mus.23869. [Epub ahead of print].
159. Olson JK, Miller SD. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol 2004;173:3916-3924.
160. Hamilton-Williams EE, Lang A, Benke D, Davey GM, Wiesmuller KH, Kurts C. Cutting edge: TLR ligands are not sufficient to break cross-tolerance to self-antigens. J Immunol 2005;174:1159-1163.
161. Gronski MA, et al. TCR affinity and negative regulation limit autoimmunity. Nat Med 2004;10:1234-1239.
162. Lang KS, et al. Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease. Nat Med 2005;11:138-145.
163. Mokhtarian F, Grob D, Griffin DE. Role of the immune response in Sindbis virus-induced paralysis of SJL/J mice. J Immunol 1989;143:633-637.